Subtype Classification Consortium for Esophageal Squamous cell carcinoma Sensitivity

Subtype Classification Consortium for Esophageal Squamous cell carcinoma Sensitivity - SUCCESS study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016141

Enrollment

300

Registered

2015-03-01

Start date

2015-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients was diagnosed newly with esophageal cancer, and will undergo a surgical treatment, radiotherapy or chemoradiotherapy. 2)Patients aged >= 20 years. 3)Written informed consent.

Exclusion criteria

Exclusion criteria: 1)Patients have received systemic chemotherapy. 2)Patients have undergone chest and mediastinum radiotherapy. 3)Patients have HBs antigen or HCV antibody 4)Patients is taking an antiplatelet agent or anticoagulant agent 5)Patients have too small esophageal cancer 6)Patients are pregnant or lactating women. 7)Patients are not suitable for this study.

Design outcomes

Primary

Measure	Time frame
Subtype classification of esophageal cancer	—

Secondary

Measure	Time frame
Correlation between subtype classification and curative effects	—

Countries

Japan

Contacts

Public ContactYusuke Amanuma

Kyoto university hospital Clinical Oncology

yusuke12@kuhp.kyoto-u.ac.jp075-751-3518

Outcome results